# A Thrombocytopenic Thrombotic Purpura in a Patient With a Metastatic HER2+ Breast Cancer: Description of a Case Report

**Authors:** Raffaele Longo, Benjamin Savenkoff, Romane Ribal, Alexandre Dadoun, Marco Campitiello, Francesca Plastino, Pierre‐Olivier Legros, Nathalie Marcon, Paul Coppo, Julie Egea

PMC · DOI: 10.1002/ccr3.70395 · 2025-04-08

## TL;DR

This case report describes a rare condition called paraneoplastic thrombotic thrombocytopenic purpura in a patient with advanced breast cancer.

## Contribution

The novelty lies in highlighting the rare association between metastatic HER2+ breast cancer and paraneoplastic TTP, emphasizing diagnostic and management challenges.

## Key findings

- The patient had metastatic HER2+ breast cancer and developed paraneoplastic TTP.
- Diagnosis and management of this rare condition are complex and challenging.
- This case underscores the importance of considering rare immune-related complications in cancer patients.

## Abstract

Paraneoplastic (p) TTP is a rare syndrome characterized by an immune‐induced, generalized microangiopathy associated with solid or hematological tumors. This case, reporting a patient with a metastatic HER2+ breast cancer and a pTTP, highlights the rarity of this entity, its difficult and challenging diagnosis, and the complexity of its management.

## Full-text entities

- **Genes:** ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** Breast Cancer (MESH:D001943), TTP (MESH:D011697), hematological tumors (MESH:D019337), Paraneoplastic (p (MESH:D010257), microangiopathy (MESH:D014652)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11978524/full.md

---
Source: https://tomesphere.com/paper/PMC11978524